Influence of bodyweight on prednisolone pharmacokinetics in dogs
PLOS One · 2025
DOI: 10.1371/journal.pone.0326586 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Bonnie L Purcell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, University of Melbourne, Werribee, Victoria, Australia. Hauptthemen laut MEDLINE: Prednisolone, Body Weight. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American College of Veterinary Internal Medicine.
Abstract (Originalsprache)
Background
Larger dogs may be at greater risk of prednisolone side effects, yet there is limited research about how bodyweight affects prednisolone pharmacokinetics in dogs. Hypothesis/objectives To describe the relationship between prednisolone dose, bodyweight, body surface area (BSA) and prednisolone area under the curve (AUC) in dogs receiving prednisolone for medical reasons. Animals 25 client owned dogs receiving prednisolone for medical reasons.
Methods
Observational population pharmacokinetic study. Liquid chromatography tandem mass spectrometry was used for plasma prednisolone quantification. Data analysis was conducted in a two-stage approach using non-compartmental modelling. A Bayesian non-linear regression model described the relationship between AUC over 8 hours ( A U C 8 h r , ng·min/mL), bodyweight and prednisolone dose.
Results
From the allometric scaling model of the form AUC 8h = A · BW B , the scaling exponent B was.83 (90% credible interval (CrI):.60–1.06) and the coefficient A was 22.8 (90% CrI: 11.8–43.4). This model suggests that equivalent exposure would be obtained using an intermediate strategy between BSA and bodyweight dosing, but the total evidence provided was relatively weak. Conclusions and clinical importance Evidence was obtained regarding the nonlinear relationship between prednisolone pharmacokinetics and bodyweight in dogs; however, this model is currently too imprecise for clinical dose determination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Clinical Sciences, University of Melbourne, Werribee, Victoria, Australia.
- Peninsula Vet Emergency and Referral Hospital, Mornington, Victoria, Australia.
- Faculty of Health, University of Canberra, Bruce, Australian Capital Territory, Australia.
- Precision One Health Initiative, University of Georgia College of Veterinary Medicine, Athens, Georgia, United States of America.
- Melbourne Mass Spectrometry and Proteomics Facility, Molecular Science & Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
- Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, United Kingdom.
ORCID-Profile: Bonnie L Purcell, Julien Rodolphe Samuel Dandrieux
Förderung
- American College of Veterinary Internal Medicine
Zitieren
APA
Purcell, B. L., Woodward, A. P., Leeming, M. G., & Dandrieux, J. R. S. (2025). Influence of bodyweight on prednisolone pharmacokinetics in dogs. PLOS One. https://doi.org/10.1371/journal.pone.0326586
Vancouver
Purcell BL, Woodward AP, Leeming MG, Dandrieux JRS. Influence of bodyweight on prednisolone pharmacokinetics in dogs. PLOS One. 2025. doi:10.1371/journal.pone.0326586
BibTeX
@article{Purcell2025,
author = {Purcell, Bonnie L and Woodward, Andrew P and Leeming, Michael G and Dandrieux, Julien Rodolphe Samuel},
title = {Influence of bodyweight on prednisolone pharmacokinetics in dogs},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0326586}
}
EUVIMED